Table 5. Cytotoxic Potency of Selected Hydrazone Derivativesa.
Comp | human U2OS | murine MNMCA1 |
---|---|---|
FG | 15.9 ± 1.2b | n.d. |
1 | 46.8 ± 12.7 | 38.5 ± 5.8 |
2 | 108.3 ± 35.4 | 28.6 ± 8.4 |
8 | 20.2 ± 1.0 | 23.5 ± 5.1 |
FIM | 4.0 ± 0.33 | 2.3 ± 0.92 |
15 | 2.6 ± 0.87 | 1.9 ± 0.33 |
19 | 24.5 ± 1.2 | 12.1 ± 2.5 |
20 | 14.3 ± 9.3 | 35.7 ± 0.67 |
PDS | >50b | 27.0 ± 16.0 |
Data are IC50 (μM, concentration inhibiting 50% of cell growth) of each compound in human osteosarcoma U2OS cells and murine fibrosarcoma MNMCA1 cells. Treatments were for 24 h in exponentially growing cells. Cell survival was evaluated with the MTT test after 48 h of cell recovery in drug-free medium. IC50 values are means ± SEM of two independent experiments performed in triplicate.
See ref (13). n.d., not determined.